Menu
Clinical trial requirements for China NMPA chemical drug registration
Date:2021-08-30
Views:612

Classification

Clinical trial

Application Catatgory

Monitoring period

1

Innovative drugs that are not marketed both domestically and abroad

 

Phase I, Il and Ill Clinical trial

 

New drug

 

5 years

2

Modified new drugs that are not marketed both domestically and abroad

 

Phase I, Il and Ill Clinical trial

 

New drug

 

2.1: 3 years

2.2: 4 years

2.3: 4 years

2.4: 3 years

3

The drugs that are imitated by domestic applications to original drugs that have been marteted abroad but not domestically

 

Pharmacokinetics (PK) and Phase Ill Clinical trial

 

Domestic generic drug

 

0 year

4

The drugs that are imitated by domestic applicants to original drugs that have been marketed domestically

 

Bioequivalence (BE) study

 

Domestic generic drug

 

0 year

5.1

Original drugs (including API and its preparation) that have been marketed abroad are applied to be marketed domestically

 

Pharmacokinetics (PK) and Phase Ill Clinical trial

 

Imported innovative drug

 

0 year

5.2

Non-original drugs (including API and its preparation) that have been marketed abroad are applied to be marketed domestically

 

Bioequivalence (BE) study

 

Imported generic drug

 

0 year